Differential effect of α-interferons on CD4- and CD8-positive lymphocytes in chronic hepatitis B virus carriers
Authors:
- G.J.M. AlexanderGAG.J.M. Alexander
- S. MagrinSMS. Magrin
- M.G. AndersonMAM.G. Anderson
- A.L.W.F. EddlestonAEA.L.W.F. Eddleston
- Roger WilliamsRWRoger Williams
- 1 January 1988
- journal article
- research article
- Published by Elsevier in Journal of Hepatology
- Vol. 7 (1) , 1-6
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- LOSS OF HBsAg WITH INTERFERON THERAPY IN CHRONIC HEPATITIS B VIRUS INFECTIONThe Lancet, 1987
- Interferon in viral hepatitis: Role in pathogenesis and treatmentHepatology, 1986
- Interferon therapy of chronic hepatitis B virus infection in ChineseJournal of Hepatology, 1986
- In Vivo Activated T Lymphocytes in the Peripheral Blood and Cerebrospinal Fluid of Patients with Multiple SclerosisNew England Journal of Medicine, 1985
- T Lymphocyte Sensitization to Hbcag and T Cell–Mediated Unresponsiveness to Hbsag in Hepatitis B Virus–Related Chronic Liver DiseaseHepatology, 1985
- In vitro α-interferon treatment of peripheral blood mononuclear cells improves interleukin-2 activity in HBV-related chronic liver diseaseJournal of Hepatology, 1985
- PATHOGENESIS OF INSULIN-DEPENDENT DIABETES: A ROLE FOR ACTIVATED T LYMPHOCYTESThe Lancet, 1984
- Effect of interferon and interferon inducers on the NK sensitivity of normal mouse thymocytes.The Journal of Immunology, 1980
- Relationship between enhanced macrophage phagocytic activity and the induction of interferon by Newcastle disease virus in mice.The Journal of Immunology, 1980
- The nature of the suppressive effect of interferon and interferon inducers on the in vitro immune responseCellular Immunology, 1976